Table 1.
Demographic and clinical characteristic of study population.
| Variable | Full Study Population (n=264) |
|---|---|
| Age in years at first cancer diagnosis (Median [IQR]) | 56 (16) |
| Sex (Count [Percent]) | |
| Male | 139 (52.7%) |
| Female | 125 (47.3%) |
| Race (Count [Percent]) | |
| White | 225 (85.2%) |
| Black | 26 (9.8%) |
| Unknown | 10 (3.8%) |
| Asian | 3 (1.1%) |
| Ethnicity (Count [Percent]) | |
| Non-Hispanic | 262 (99.2%) |
| Hispanic | 2 (0.8%) |
| Primary Cancer type (Count [Percent]) | |
| Breast | 39 (14.8%) |
| Colorectal | 32 (12.1%) |
| Pancreatic | 30 (11.4%) |
| Prostate | 27 (10.2%) |
| Soft tissue sarcoma | 18 (6.8%) |
| Ovarian | 11 (4.2%) |
| Bladder | 9 (3.4%) |
| Esophageal | 9 (3.4%) |
| Cholangiocarcinoma | 8 (3.0%) |
| Head and neck | 8 (3.0%) |
| Non-small cell lung | 8 (3.0%) |
| Glioblastoma | 7 (2.7%) |
| Melanoma | 5 (1.9%) |
| Renal | 5 (1.9%) |
| Other* | 48 (18.2%) |
*The “other” category consisted of all primary cancer types which occurred in fewer than 5 patients in our study population.